| View |
|
DR-XY30144
|
Diclofenac Sodium
|
Lofenax
|
25mg/mL
|
Solution For Injection
|
-
|
Geofman Pharmaceuticals
|
Pakistan
|
Automatic Renewal
|
10 November 2022
|
15 October 2027
|
| View |
|
DR-XY30153
|
None
|
Ranitidine (As Hydrochloride)
|
75 mg
|
Tablet
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
-
|
18 May 2021
|
19 October 2026
|
| View |
|
DR-XY30163
|
Paracetamol
|
Poro
|
250 mg/5 mL
|
Suspension
|
Analgesic/Antipyretic
|
Y.S.P. Industries (M) Sdn. Bhd.
|
Malaysia
|
Renewal
|
06 July 2024
|
21 October 2029
|
| View |
|
DR-XY30170
|
Epirubicin Hydrochloride
|
Neoquabin
|
10 mg
|
Lyophilized Powder for Injection (IV)
|
Antineoplastic
|
Korea United Pharm. Inc.
|
Korea
|
Renewal
|
15 May 2024
|
21 October 2029
|
| View |
|
DR-XY30171
|
Epirubicin Hydrochloride
|
Neoquabin
|
50 mg
|
Lyophilized Powder for Injection (IV)
|
Antineoplastic
|
Korea United Pharm. Inc.
|
Korea
|
Renewal
|
21 April 2024
|
21 October 2029
|
| View |
|
DR-XY30177
|
Potassium Iodide/ Sodium Iodide
|
VISTALENS
|
3mg/ 3mg per mL
|
Ophthalmic Solution
|
Lens Nutrient
|
E.L. Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 July 2022
|
20 June 2027
|
| View |
|
DR-XY30184
|
Metoclopramide Hydrochloride
|
Liothyl
|
10mg Film-Coated
|
Tablet
|
Gastrokinetic
|
YSP Industries (M) Sdn. Bhd.
|
Malaysia
|
Renewal
|
14 June 2024
|
28 October 2029
|
| View |
|
DR-XY30200
|
Phenylpropanolamine Hydrochloride
|
Crolameen
|
6.25 mg/mL
|
Syrup (Oral Drops)
|
Nasal Decongestant
|
La Croesus Pharma, Inc.
|
Philippines
|
Renewal
|
05 February 2024
|
19 February 2029
|
| View |
|
DR-XY30213
|
Chloramphenicol
|
Medichlor
|
500 mg
|
Capsule
|
Antibacterial (Amphenicols)
|
Flamingo Pharmaceuticals Ltd.
|
India
|
Renewal
|
23 June 2024
|
02 November 2029
|
| View |
|
DR-XY30219
|
Phenylpropanolamine Hydrochloride
|
Crolameen
|
12.5mg/5mL
|
Syrup
|
Nasal Decongestant
|
La Croesus Pharma, Inc.
|
Philippines
|
Renewal
|
27 February 2024
|
19 February 2029
|
| View |
|
DR-XY30225
|
Tranexamic Acid
|
Dostan
|
500 mg
|
Film-Coated Tablet
|
Antifibrinolytic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
24 June 2024
|
05 November 2029
|
| View |
|
DR-XY30242
|
Zoledronic acid
|
Zometa
|
4 mg/5 mL
|
Concentrate For Solustion For I.V. Infusion
|
Bisphosphonate
|
Novartis Pharma Stein AG, Pharmaceutical Operations Schweiz
|
Switzerland
|
Renewal
|
19 December 2023
|
09 January 2029
|
| View |
|
DR-XY30243
|
MOMETASONE FUROATE
|
MOMATE
|
0.1% w/w
|
Ointment
|
Topical Corticosteroid
|
Glenmark Pharmaceuticals Ltd.
|
India
|
Automatic Renewal
|
07 December 2021
|
10 November 2026
|
| View |
|
DR-XY30246
|
Diphenhydramine Hydrochloride
|
Benaxil
|
50mg/mL
|
Solution For Injection (I.M/I.V.)
|
Anticholinergic / H1 Receptor Antagonist
|
Yoo Young Pharmaceutical Co., Ltd.
|
Korea
|
Renewal
|
04 August 2024
|
09 November 2029
|
| View |
|
DR-XY30251
|
LIDOCAINE HYDROCHLORIDE + EPINEPHRINE
|
ALPHACAINE
|
20 mg/10mcg per Ml
|
Solution For Injection
|
INFILTRATION ANESTHESIA
|
DFL Industria E. Comercio, S.A.
|
Brazil
|
Renewal
|
12 October 2024
|
10 November 2029
|
| View |
|
DR-XY30280
|
Calcium Polystyrene Sulfonate
|
Kalimate
|
5g
|
Powder For Suspension
|
Potassium removing exchange resin
|
Kowa Pharmaceutical Company Ltd.
|
Japan
|
Renewal
|
09 November 2024
|
12 November 2029
|
| View |
|
DR-XY30281
|
Atenolol
|
None
|
100 mg
|
Tablet
|
Beta-Adrenoreceptor Blockers
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
27 June 2022
|
12 September 2027
|
| View |
|
DR-XY30296
|
Multivitamins + Flouride
|
None
|
1/500 I.U/ 400 I.U/ 5 I.U/ 500mcg/ 600mcg/ 8mg/ 400mcg/ 2mcg/ 35mg/ 250mcg
|
Syrup (Oral Drops)
|
-
|
DRUGMAKER'S LABORATORIES, INC.
|
Philippines
|
Automatic Renewal
|
26 November 2021
|
10 December 2026
|
| View |
|
DR-XY30342
|
Atenolol
|
None
|
50 mg
|
Tablet
|
Beta-Adrenoceptor Blocker
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 February 2022
|
30 May 2027
|
| View |
|
DR-XY30344
|
Metoprolol Tartrate
|
Metorpim
|
50 mg
|
Film-Coated Tablet
|
Beta Adrenoceptor Blocker
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
16 January 2024
|
19 January 2029
|